ancient DNA for Modern Genomics (aDMG) Research Projects (U01 Clinical Trials Not Allowed)
National Institutes of Health
Classification and identifiers
- Solicitation number
- RFA-HG-28-003
- Assistance listing (CFDA)
- 93.172
Amount
Amount not published by the funder
Who can apply
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
About this opportunity
The National Human Genome Research Institute (NHGRI) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications to establish an ancient DNA for Modern Genomics (aDMG) program. The goal of aDMG is to establish an ethical resource of ancient and historical human DNA (aDNA) data to advance studies about contemporary human traits and biology. This NOFO aims to solicit applications that will leverage existing and newly generated aDNA data from this consortium to advance the biological and epidemiological understanding of modern human diseases and health-related traits by integrating aDNA with modern human and other species’ data. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO w...
Related opportunities
- Genomic Community Resources (U24 Clinical Trials Not Allowed)National Institutes of Health
- ancient DNA for Modern Genomics (aDMG) Coordination CenterNational Institutes of Health
- ancient DNA for Modern Genomics (aDMG) Data Generation and Resource CenterNational Institutes of Health
- Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)National Institutes of Health
- Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)National Institutes of HealthCloses Feb 2027
- Limited Competition: The NHGRI Analysis, Visualization, and Informatics Lab-space (AnVIL) (U54 Clinical Trial Not Allowed)National Institutes of Health